Novel 2-methoxy-4-(((3-methyl-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl)-imino)-methyl)-phenyl benzoate as a potential drug candidate: Synthesis, spectroscopy, TD-DFT, NBO, TDM, FMO, MEP, molecular docking, and molecular dynamics studies
Yazarlar (9)
Doç. Dr. Ahmet HARMANKAYA Kafkas Üniversitesi, Türkiye
Hilal Medetalibeyoğlu Kafkas Üniversitesi, Türkiye
Ahmet Buğra Ortaakarsu
Gazi Üniversitesi, Türkiye
Doç. Dr. Abdurrahman Atalay Avrasya Üniversitesi, Türkiye
Sevda Manap Kafkas Üniversitesi, Türkiye
Prof. Dr. Ebru Koca Kafkas Üniversitesi, Türkiye
Çiğdem Yıldız
Kafkas Üniversitesi, Türkiye
Nejdet Köçek
Kafkas Üniversitesi, Türkiye
Haydar Yüksek Kafkas Üniversitesi, Türkiye
Devamını Göster...
Makale Türü Özgün Makale (SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale)
Dergi Adı Journal of Molecular Structure (Q2)
Dergi ISSN 0022-2860 Dergi Bilgileri (2025)
Dergi Tarandığı Indeksler SCI-Expanded
Makale Dili Türkçe Basım Tarihi 08-2025
Kabul Tarihi – Yayınlanma Tarihi 01-08-2025
Cilt / Sayı / Sayfa 1338 / 1 / – DOI 10.1016/j.molstruc.2025.142286
Makale Linki https://doi.org/10.1016/j.molstruc.2025.142286
UAK Araştırma Alanları
Eczacılık Biyokimyası
Özet
A promising novel drug candidate, 2‑methoxy-4-[((3-methyl-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl)-imino)-methyl]-phenyl benzoate (3), has been successfully synthesized through the condensation reaction of 4-formyl-2-methoxyphenyl benzoate and 4-amino-5-methyl-2,4-dihydro-3H-1,2,4-triazol-3-one. The synthesis process demonstrated a good yield, and the compound underwent thorough characterization using 1H\13C NMR, IR, and UV–Vis spectroscopic techniques. A newly synthesized compound, 2‑methoxy-4-(((3-methyl-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl)-imino)-methyl)-phenyl benzoate (3), has been performed structural analysis utilizing a combination of experimental and theoretical methods. The analysis process involved the use of FT-IR and NMR spectroscopy alongside the evaluation of various electronic parameters, including global reactivity parameters, FMO, NBO, MEP, ELF, LOL, TDM, NLO, and UV, using the IEFPCM model. A comprehensive molecular docking study was conducted to analyze the binding mode interactions between compound 3 and the targeted enzymes (AChE, BChE, COX-1, and COX-2). The results indicate that the strength of intermolecular hydrogen bonding in ligand-receptor complexes is crucial in explaining the observed inhibition outcomes. Furthermore, molecular dynamics simulations are conducted to analyze the protein-ligand complex and assess the stability of the compound within a protein environment.
Anahtar Kelimeler
Molecular docking | Molecular dynamic simulations | NBO | TDM | Triazole